Yilong Wang
Researcher Next ID · RN-022594
Researcher · Medicine
London, Taiwan
- Works count
- 513
- Citation count
- 25,272
- H-index
- 68
- i10-index
- 294
Research interests
Publications
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(22)02600-9
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2213379
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(22)02600-9
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuros
Stroke and Vascular Neurology · 2022 · https://doi.org/10.1136/svn-2021-001374
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuros
Stroke and Vascular Neurology · 2022 · https://doi.org/10.1136/svn-2021-001374
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China
Stroke · 2021 · https://doi.org/10.1161/strokeaha.120.031869
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2111749
Stroke in China: advances and challenges in epidemiology, prevention, and management
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30500-3
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1802686
Artificial intelligence in healthcare: past, present and future
Stroke and Vascular Neurology · 2017 · https://doi.org/10.1136/svn-2017-000101
Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies
American Journal of Clinical Nutrition · 2017 · https://doi.org/10.3945/ajcn.116.140392
Prevalence, Incidence, and Mortality of Stroke in China
Circulation · 2017 · https://doi.org/10.1161/circulationaha.116.025250
Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
JAMA · 2016 · https://doi.org/10.1001/jama.2016.8662
Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China
Stroke · 2014 · https://doi.org/10.1161/strokeaha.113.003508
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215340
The China National Stroke Registry for Patients with Acute Cerebrovascular Events: Design, Rationale, and Baseline Patient Characteristics
International Journal of Stroke · 2011 · https://doi.org/10.1111/j.1747-4949.2011.00584.x
The China National Stroke Registry for Patients with Acute Cerebrovascular Events: Design, Rationale, and Baseline Patient Characteristics
International Journal of Stroke · 2011 · https://doi.org/10.1111/j.1747-4949.2011.00584.x
Current projects
No projects listed.